Raghuram Selvaraju

Stock Analyst at HC Wainwright & Co.

(1.98)
# 1,655
Out of 4,442 analysts
617
Total ratings
36.86%
Success rate
n/a
Average return

90 Stocks

Scilex Holding Company
May 23, 2024
Maintains: Buy
Price Target: $8$7
Current: $1.13
Upside: +519.47%
Arcadia Biosciences
May 23, 2024
Maintains: Buy
Price Target: $10$6
Current: $2.93
Upside: +105.13%
Sol-Gel Technologies
May 22, 2024
Reiterates: Buy
Price Target: $6
Current: $0.80
Upside: +650.00%
Oramed Pharmaceuticals
May 20, 2024
Reiterates: Neutral
Price Target: n/a
Current: $2.34
Upside: -
Genmab
May 20, 2024
Reiterates: Buy
Price Target: $50
Current: $28.00
Upside: +78.57%
BridgeBio Pharma
May 20, 2024
Maintains: Buy
Price Target: $47$43
Current: $27.94
Upside: +53.90%
MoonLake Immunotherapeutics
May 17, 2024
Reiterates: Buy
Price Target: $100
Current: $40.85
Upside: +144.80%
Longeveron
May 17, 2024
Reiterates: Buy
Price Target: $12
Current: $1.10
Upside: +990.91%
Equillium
May 17, 2024
Reiterates: Buy
Price Target: $5
Current: $1.40
Upside: +257.14%
Fate Therapeutics
May 16, 2024
Maintains: Neutral
Price Target: $7$5
Current: $3.52
Upside: +42.05%
Ovid Therapeutics
May 16, 2024
Reiterates: Buy
Price Target: $9
Current: $3.00
Upside: +200.00%
Rockwell Medical
May 16, 2024
Reiterates: Buy
Price Target: $9
Current: $1.81
Upside: +397.24%
Spero Therapeutics
May 16, 2024
Reiterates: Buy
Price Target: $7
Current: $1.47
Upside: +376.19%
Gain Therapeutics
May 15, 2024
Reiterates: Buy
Price Target: $9
Current: $2.42
Upside: +271.90%
Fennec Pharmaceuticals
May 15, 2024
Maintains: Buy
Price Target: $18$15
Current: $6.70
Upside: +123.88%
Verona Pharma
May 15, 2024
Reiterates: Buy
Price Target: $32
Current: $12.04
Upside: +165.78%
Entera Bio
May 14, 2024
Reiterates: Buy
Price Target: $10
Current: $2.32
Upside: +331.03%
Cocrystal Pharma
May 14, 2024
Reiterates: Buy
Price Target: $10
Current: $2.16
Upside: +362.96%
UroGen Pharma
May 14, 2024
Reiterates: Buy
Price Target: $54
Current: $13.24
Upside: +307.85%
Spruce Biosciences
May 14, 2024
Reiterates: Neutral
Price Target: n/a
Current: $0.70
Upside: -
Oncternal Therapeutics
May 13, 2024
Maintains: Buy
Price Target: $28$19
Current: $9.21
Upside: +106.30%
Processa Pharmaceuticals
May 13, 2024
Reiterates: Buy
Price Target: $8
Current: $1.80
Upside: +344.44%
Annovis Bio
May 13, 2024
Maintains: Buy
Price Target: $30$23
Current: $7.29
Upside: +215.50%
ADMA Biologics
May 10, 2024
Maintains: Buy
Price Target: $7.5$10
Current: $9.56
Upside: +4.60%
BioXcel Therapeutics
May 10, 2024
Reiterates: Buy
Price Target: $10
Current: $1.86
Upside: +437.63%
Kezar Life Sciences
May 10, 2024
Reiterates: Buy
Price Target: $20
Current: $0.71
Upside: +2,736.88%
Anavex Life Sciences
May 10, 2024
Reiterates: Buy
Price Target: $40
Current: $4.00
Upside: +900.00%
Regulus Therapeutics
May 10, 2024
Reiterates: Buy
Price Target: $9
Current: $2.02
Upside: +345.54%
ChromaDex
May 9, 2024
Reiterates: Buy
Price Target: $6
Current: $3.12
Upside: +92.31%
PolyPid
May 9, 2024
Reiterates: Buy
Price Target: $14
Current: $4.34
Upside: +222.58%
Aquestive Therapeutics
May 9, 2024
Reiterates: Buy
Price Target: $9
Current: $3.06
Upside: +194.12%
BrainsWay
May 9, 2024
Maintains: Buy
Price Target: $13$15
Current: $5.40
Upside: +177.78%
Axsome Therapeutics
May 7, 2024
Reiterates: Buy
Price Target: $190
Current: $75.19
Upside: +152.69%
Balchem
May 6, 2024
Maintains: Buy
Price Target: $167$170
Current: $153.02
Upside: +11.10%
Cardiff Oncology
May 6, 2024
Reiterates: Buy
Price Target: $14
Current: $3.44
Upside: +306.98%
Enlivex Therapeutics
Apr 23, 2024
Reiterates: Buy
Price Target: $7
Current: $1.40
Upside: +400.00%
Reviva Pharmaceuticals Holdings
Apr 22, 2024
Reiterates: Buy
Price Target: $20
Current: $1.53
Upside: +1,207.19%
Microbot Medical
Apr 16, 2024
Maintains: Buy
Price Target: $8$7
Current: $1.02
Upside: +586.27%
Indaptus Therapeutics
Apr 15, 2024
Reiterates: Buy
Price Target: $12
Current: $2.34
Upside: +412.82%
RAPT Therapeutics
Apr 10, 2024
Reiterates: Neutral
Price Target: n/a
Current: $4.18
Upside: -
Hoth Therapeutics
Apr 5, 2024
Reiterates: Buy
Price Target: $4
Current: $1.22
Upside: +227.87%
Entrada Therapeutics
Mar 18, 2024
Reiterates: Buy
Price Target: $20
Current: $15.13
Upside: +32.19%
Aclaris Therapeutics
Jan 22, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.11
Upside: -
Taro Pharmaceutical Industries
Jan 18, 2024
Downgrades: Neutral
Price Target: $43
Current: $42.69
Upside: +0.73%
Cingulate
Jan 5, 2024
Maintains: Buy
Price Target: $3.5$8
Current: $0.79
Upside: +914.33%
Eton Pharmaceuticals
Dec 11, 2023
Reiterates: Buy
Price Target: $10
Current: $3.58
Upside: +179.33%
PaxMedica
Dec 4, 2023
Initiates: Buy
Price Target: $3
Current: $0.31
Upside: +857.85%
Protalix BioTherapeutics
Nov 14, 2023
Reiterates: Buy
Price Target: $10
Current: $1.23
Upside: +713.01%
Aeterna Zentaris
Nov 13, 2023
Maintains: Buy
Price Target: $112$60
Current: $8.37
Upside: +616.85%
Galecto
Sep 28, 2023
Downgrades: Neutral
Price Target: n/a
Current: $0.63
Upside: -
Ensysce Biosciences
Sep 25, 2023
Maintains: Buy
Price Target: $9$7
Current: $0.57
Upside: +1,128.07%
Anebulo Pharmaceuticals
Sep 25, 2023
Reiterates: Buy
Price Target: $6
Current: $2.12
Upside: +183.69%
Galera Therapeutics
Aug 16, 2023
Downgrades: Neutral
Price Target: $6$0.3
Current: $0.20
Upside: +53.06%
Evofem Biosciences
Aug 15, 2022
Maintains: Buy
Price Target: $250$500
Current: $0.02
Upside: +3,124,900.00%
Addex Therapeutics
Jun 23, 2022
Downgrades: Neutral
Price Target: n/a
Current: $8.01
Upside: -
Tyra Biosciences
Jun 23, 2022
Initiates: Buy
Price Target: $12
Current: $17.32
Upside: -30.72%
NeuBase Therapeutics
May 31, 2022
Maintains: Buy
Price Target: $300$200
Current: $0.38
Upside: +52,810.05%
InMed Pharmaceuticals
Nov 29, 2021
Initiates: Buy
Price Target: n/a
Current: $0.30
Upside: -
Abeona Therapeutics
Nov 29, 2021
Maintains: Buy
Price Target: n/a
Current: $4.06
Upside: -
Omeros
Oct 19, 2021
Maintains: Buy
Price Target: n/a
Current: $3.35
Upside: -
Synlogic
Oct 13, 2021
Maintains: Buy
Price Target: n/a
Current: $1.60
Upside: -
RedHill Biopharma
Sep 15, 2021
Maintains: Buy
Price Target: n/a
Current: $0.46
Upside: -
Immunic
Sep 7, 2021
Maintains: Buy
Price Target: n/a
Current: $1.25
Upside: -
Exicure
May 17, 2021
Maintains: Buy
Price Target: n/a
Current: $0.33
Upside: -
Repligen
May 5, 2021
Maintains: Buy
Price Target: n/a
Current: $158.16
Upside: -
Bausch Health Companies
Mar 16, 2021
Maintains: Buy
Price Target: n/a
Current: $6.36
Upside: -
TFF Pharmaceuticals
Mar 5, 2021
Maintains: Buy
Price Target: $775$925
Current: $2.21
Upside: +41,755.20%
NeuroBo Pharmaceuticals
Feb 1, 2021
Maintains: Buy
Price Target: $4,800$3,840
Current: $4.13
Upside: +92,878.21%
Applied DNA Sciences
Jan 14, 2021
Maintains: Buy
Price Target: $360$280
Current: $1.99
Upside: +13,970.35%
CareDx
Aug 5, 2020
Maintains: Buy
Price Target: n/a
Current: $15.94
Upside: -
CytoDyn
Jul 6, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.24
Upside: -
Replimune Group
Jul 1, 2020
Downgrades: Neutral
Price Target: n/a
Current: $5.22
Upside: -
IGM Biosciences
Jul 1, 2020
Initiates: Buy
Price Target: n/a
Current: $9.55
Upside: -
Inovio Pharmaceuticals
Jun 29, 2020
Downgrades: Neutral
Price Target: n/a
Current: $11.00
Upside: -
Evoke Pharma
Jun 22, 2020
Upgrades: Buy
Price Target: n/a
Current: $0.43
Upside: -
BioLife Solutions
Mar 23, 2020
Maintains: Buy
Price Target: n/a
Current: $21.72
Upside: -
SpringWorks Therapeutics
Mar 19, 2020
Upgrades: Buy
Price Target: n/a
Current: $42.38
Upside: -
Celcuity
Nov 20, 2018
Initiates: Buy
Price Target: n/a
Current: $15.64
Upside: -
CytomX Therapeutics
Sep 13, 2018
Initiates: Buy
Price Target: n/a
Current: $1.75
Upside: -
Kala Pharmaceuticals
Aug 24, 2018
Maintains: Buy
Price Target: n/a
Current: $6.51
Upside: -
CorMedix
May 23, 2018
Maintains: Buy
Price Target: n/a
Current: $5.12
Upside: -
Check-Cap
May 23, 2018
Maintains: Buy
Price Target: n/a
Current: $2.27
Upside: -
T2 Biosystems
Mar 29, 2018
Maintains: Buy
Price Target: $40,000$42,500
Current: $4.95
Upside: +858,485.86%
DURECT
Mar 6, 2018
Upgrades: Buy
Price Target: n/a
Current: $1.30
Upside: -
DENTSPLY SIRONA
Mar 5, 2018
Maintains: Neutral
Price Target: n/a
Current: $27.46
Upside: -
Aethlon Medical
Nov 20, 2017
Initiates: Buy
Price Target: n/a
Current: $0.42
Upside: -
Bio-Path Holdings
Nov 13, 2017
Maintains: Buy
Price Target: $18,000$6,000
Current: $2.03
Upside: +295,466.50%
Immuron
Oct 18, 2017
Initiates: Buy
Price Target: n/a
Current: $2.25
Upside: -
Ocular Therapeutix
Jul 26, 2017
Initiates: Buy
Price Target: n/a
Current: $5.80
Upside: -
Alimera Sciences
Apr 27, 2017
Initiates: Buy
Price Target: n/a
Current: $2.95
Upside: -